Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT04848961

A Study to Develop a Strategy to Increase Lung Cancer Screening in Women Who May Be at Risk for Lung Cancer

The purpose of this study is to develop a digital strategy to increase awareness about lung cancer screening among women who are eligible to receive it. The digital strategy involves email communications and LungTalk, a web-based (accessed through the Internet) health communication tool that uses text, audio, video, and animation to increase awareness and knowledge about lung cancer screening. This study will focus on women who have recently received a screening mammogram.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Age range

50 year–80 year

Sex eligibility

Female

Study type

Interventional

Phase

Early Phase 1

Primary location

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • LDCT screening-eligible women who received a BiRADS 1 (negative) or 2 (benign/non-cancerous finding) result from a screening mammogram in the last 7 days
  • Age 50-80 years
  • ≥ 20-pack-year smoking history of combustible cigarettes as per self report
  • Women who currently smoke or quit within past 15 years as per self report
  • Lung screening naïve as per self-report

Exclusion criteria

  • Lung cancer diagnosis
  • Chest CT within the last 12 months

Treatment and study plan

LungTalk

Behavioral

MSK developed LungTalk, a novel computer-tailored health communication and decision support tool to (1) increase awareness and knowledge about lung screening; (2) decrease perceived barriers to screening based upon misinformation; and (3) increase screening rates.

Primary outcomes

  1. Number of participants accrued through digital outreach to identify breast screening participants eligible for lung screening

    Time frame: 6 months

    Develop a proactive digital outreach and engagement strategy to identify breast screening patients who are eligible for lung screening.

Sponsors and collaborators

Lead sponsor

Memorial Sloan Kettering Cancer Center

Other

Registry information

Official study title

Leveraging Mammography to Identify and Engage Women at Risk for Lung Cancer in Lung Cancer Screening

Important dates

Study start
2021
Primary completion
2027
Study completion
2027
First posted
Apr 19, 2021
Registry last updated
May 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.